ARTV Sale Disclosure
Aslan Fred · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$259.97K
Aslan Fred Chief Executive Officer
ARTV
Transaction date
Nov 2, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 1 day later
ARTV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 62,178 shares @ $4.18
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-445312
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$259.97K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. ARTV Current | Sale | Nov 2, 2026 | $259.97K |